ROBERTS EIRY
Insider CIK 1727606 · FOLD Director · BHC Director · NBIX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies In | A Award | 2026-05-22 | 2026-05-26 | 45,871 | — | $0 | 45,871 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 74,872 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 42,467 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 30,474 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 45,423 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 40,625 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer | 2026-04-27 | 2026-04-27 | 76,275 | $14.50 | $1.11M | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2025-06-05 | 2025-06-06 | 74,872 | — | $0 | 74,872 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2025-06-05 | 2025-06-06 | 20,414 | — | $0 | 76,275 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-14 | 2025-02-14 | 500 | $115.04 | $57.5K | 35,640 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 1,120 | — | $0 | 3,363 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 2,113 | — | $0 | 4,227 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 1,372 | — | $0 | 4,115 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 1,114 | $116.90 | $130.2K | 34,252 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 2,113 | — | $0 | 35,366 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 1,120 | — | $0 | 35,372 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 1,372 | — | $0 | 36,140 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 604 | $116.74 | $70.5K | 34,768 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-02-12 | 2025-02-14 | 8,108 | — | $0 | 8,108 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-02-12 | 2025-02-14 | 43,261 | — | $0 | 43,261 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-10 | 2025-02-12 | 980 | $118.22 | $115.9K | 33,253 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-08 | 2025-02-12 | 1,860 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-08 | 2025-02-12 | 1,860 | — | $0 | 34,233 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-01-31 | 2025-02-04 | 2,769 | — | $0 | 2,769 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-01-31 | 2025-02-04 | 2,769 | — | $0 | 33,830 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-01-31 | 2025-02-04 | 1,457 | $152.80 | $222.6K | 32,373 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-12-17 | 2024-12-19 | 5,487 | — | $0 | 5,487 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-12-17 | 2024-12-19 | 27,770 | — | $0 | 27,770 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-11-08 | 2024-11-12 | 1 | — | $0 | 1,265 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-11-08 | 2024-11-12 | 1,233 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-11-08 | 2024-11-12 | 971 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-11-08 | 2024-11-12 | 5,140 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-11-08 | 2024-11-12 | 1,233 | $81.05 | $99.9K | 30,089 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-11-08 | 2024-11-12 | 5,140 | $77.81 | $399.9K | 28,856 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-11-08 | 2024-11-12 | 971 | $102.90 | $99.9K | 31,060 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-11-08 | 2024-11-12 | 1 | $79.02 | $79 | 31,061 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2024-06-06 | 2024-06-07 | 42,467 | — | $0 | 42,467 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2024-06-06 | 2024-06-07 | 11,847 | — | $0 | 55,861 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-02-13 | 2024-02-15 | 22,529 | — | $0 | 22,529 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-02-13 | 2024-02-15 | 4,483 | — | $0 | 4,483 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-13 | 2024-02-15 | 1,114 | $132.96 | $148.1K | 23,716 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-08 | 2024-02-08 | 980 | $134.21 | $131.5K | 22,717 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-06 | 2024-02-08 | 1,121 | $142.24 | $159.5K | 21,837 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-01-31 | 2024-02-02 | 1,457 | $140.79 | $205.1K | 20,832 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-12-22 | 2023-12-27 | 10,000 | $126.74 | $1.27M | 19,521 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-12-12 | 2023-12-14 | 6,978 | $81.05 | $565.6K | 46,387 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-12-12 | 2023-12-14 | 6,947 | $81.05 | $563.1K | 39,440 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-12-12 | 2023-12-14 | 6,947 | $120.31 | $835.8K | 29,521 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-12-12 | 2023-12-14 | 6,978 | $81.05 | $565.6K | 36,499 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-12-12 | 2023-12-14 | 6,978 | $120.30 | $839.5K | 29,521 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-12-12 | 2023-12-14 | 6,947 | $81.05 | $563.1K | 36,468 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-12-08 | 2023-12-11 | 200 | $81.05 | $16.2K | 53,465 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-12-08 | 2023-12-11 | 100 | $81.05 | $8.1K | 53,365 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-12-08 | 2023-12-11 | 100 | $81.05 | $8.1K | 29,621 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-12-08 | 2023-12-11 | 200 | $120.16 | $24.0K | 29,521 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-12-08 | 2023-12-11 | 200 | $81.05 | $16.2K | 29,721 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-12-08 | 2023-12-11 | 100 | $120.00 | $12.0K | 29,521 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-12-07 | 2023-12-11 | 14,140 | $79.02 | $1.12M | 60,005 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-12-07 | 2023-12-11 | 11,775 | $81.05 | $954.4K | 53,665 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-12-07 | 2023-12-11 | 38,722 | $77.81 | $3.01M | 12,742 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-12-07 | 2023-12-11 | 12,742 | $77.81 | $991.5K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-12-07 | 2023-12-11 | 14,140 | $120.37 | $1.70M | 29,521 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-12-07 | 2023-12-11 | 38,722 | $77.81 | $3.01M | 68,243 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-12-07 | 2023-12-11 | 11,775 | $120.37 | $1.42M | 29,521 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-12-07 | 2023-12-11 | 11,775 | $81.05 | $954.4K | 41,296 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-12-07 | 2023-12-11 | 14,140 | $79.02 | $1.12M | 43,661 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-12-07 | 2023-12-11 | 12,742 | $120.37 | $1.53M | 29,521 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-12-07 | 2023-12-11 | 12,742 | $77.81 | $991.5K | 42,263 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-12-07 | 2023-12-11 | 38,722 | $120.37 | $4.66M | 29,521 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-12-06 | 2023-12-08 | 8,396 | $77.81 | $653.3K | 51,464 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-12-06 | 2023-12-08 | 8,396 | $77.81 | $653.3K | 37,917 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-12-06 | 2023-12-08 | 8,396 | $120.03 | $1.01M | 29,521 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-08-21 | 2023-08-23 | 3,198 | $107.38 | $343.4K | 29,521 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2023-06-08 | 2023-06-12 | 30,474 | — | $0 | 30,474 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2023-06-08 | 2023-06-12 | 8,584 | — | $0 | 44,014 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-04-24 | 2023-04-26 | 14,400 | $103.48 | $1.49M | 26,644 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-02-13 | 2023-02-15 | 52,532 | — | $0 | 52,532 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-02-13 | 2023-02-15 | 8,453 | — | $0 | 8,453 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-08 | 2023-02-08 | 980 | $104.16 | $102.1K | 41,015 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-07 | 2023-02-08 | 12,801 | $102.41 | $1.31M | 40,135 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-07 | 2023-02-08 | 1,623 | $102.35 | $166.1K | 28,638 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-06 | 2023-02-08 | 1,121 | $105.80 | $118.6K | 27,176 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-01-31 | 2023-02-02 | 1,457 | $109.99 | $160.3K | 26,171 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2022-06-09 | 2022-06-10 | 45,423 | — | $0 | 45,423 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2022-06-09 | 2022-06-10 | 12,671 | — | $0 | 35,430 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-08 | 2022-02-09 | 980 | $79.52 | $77.9K | 24,625 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-07 | 2022-02-09 | 1,121 | $80.80 | $90.6K | 23,746 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-07 | 2022-02-09 | 1,623 | $80.77 | $131.1K | 22,741 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-01-31 | 2022-02-02 | 11,074 | — | $0 | 11,074 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-01-31 | 2022-02-02 | 75,411 | — | $0 | 75,411 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-01-10 | 2022-01-12 | 2,632 | $74.50 | $196.1K | 21,279 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 40,625 | — | $0 | 40,625 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2021-06-10 | 2021-06-14 | 22,759 | — | $0 | 22,759 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-02-08 | 2021-02-09 | 7,439 | — | $0 | 7,439 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-02-08 | 2021-02-09 | 44,632 | — | $0 | 44,632 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-02-08 | 2021-03-29 | 49,049 | — | $0 | 49,049 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-08 | 2021-02-09 | 740 | $116.67 | $86.3K | 17,231 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-08 | 2021-02-09 | 1,623 | $116.83 | $189.6K | 18,693 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-01-08 | 2021-01-12 | 2,632 | $111.06 | $292.3K | 15,845 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-11-12 | 2020-11-16 | 2,257 | $90.74 | $204.8K | 13,477 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-08-05 | 2020-08-07 | 2,257 | $118.84 | $268.2K | 11,446 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2020-06-23 | 2020-06-25 | 5,000 | $77.81 | $389.1K | 59,860 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-06-23 | 2020-06-25 | 5,000 | $130.00 | $650.0K | 9,416 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2020-06-23 | 2020-06-25 | 5,000 | $77.81 | $389.1K | 14,416 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-04-24 | 2020-04-28 | 1,934 | $99.47 | $192.4K | 9,416 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-02-07 | 2020-02-11 | 1,623 | $103.31 | $167.7K | 7,452 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-02-06 | 2020-02-07 | 8,504 | — | $0 | 8,504 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-02-06 | 2020-02-07 | 53,678 | — | $0 | 53,678 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-01-08 | 2020-01-10 | 2,632 | $111.11 | $292.4K | 5,991 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-02-07 | 2019-02-08 | 66,673 | — | $0 | 66,673 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-02-07 | 2019-02-08 | 12,339 | — | $0 | 12,339 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-01-08 | 2019-01-10 | 1,857 | $84.09 | $156.2K | 3,143 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-02-05 | 2018-02-07 | 18,400 | — | $0 | 18,400 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-02-05 | 2018-02-07 | 12,250 | — | $0 | 12,250 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-01-08 | 2018-01-10 | 70,000 | — | $0 | 70,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-01-08 | 2018-01-10 | 20,000 | — | $0 | 20,000 | SEC↗ |